BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 28581671)

  • 1. Digital image analysis supports a nuclear-to-cytoplasmic ratio cutoff value of 0.5 for atypical urothelial cells.
    Hang JF; Charu V; Zhang ML; VandenBussche CJ
    Cancer Cytopathol; 2017 Sep; 125(9):710-716. PubMed ID: 28581671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digital image analysis supports a nuclear-to-cytoplasmic ratio cutoff value below 0.7 for positive for high-grade urothelial carcinoma and suspicious for high-grade urothelial carcinoma in urine cytology specimens.
    McIntire PJ; Snow JT; Elsoukkary SS; Soong L; Sweeney J; Robinson BD; Siddiqui MT
    Cancer Cytopathol; 2019 Feb; 127(2):120-124. PubMed ID: 30395388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Split-sample comparison of urothelial cells in ThinPrep and cytospin preparations in urinary cytology: Do we need to adjust The Paris System for Reporting Urinary Cytology criteria?
    Richardson CJ; Pambuccian SE; Barkan GA
    Cancer Cytopathol; 2020 Feb; 128(2):119-125. PubMed ID: 31774630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved risk stratification for patients with high-grade urothelial carcinoma following application of the Paris System for Reporting Urinary Cytology.
    Cowan ML; Rosenthal DL; VandenBussche CJ
    Cancer Cytopathol; 2017 Jun; 125(6):427-434. PubMed ID: 28272842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Paris System for urine cytology in upper tract urothelial specimens: A comparative analysis with biopsy and surgical resection.
    Zheng X; Si Q; Du D; Harshan M; Zhang Z; Haines K; Shi W; Chhieng DC
    Cytopathology; 2018 Apr; 29(2):184-188. PubMed ID: 29251368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative cytomorphological comparison of SurePath and ThinPrep liquid-based cytology using high-grade urothelial carcinoma cells.
    Okuda C; Kyotake A; Nakamura A; Itoh T; Kamoshida S; Ohsaki H
    Cytopathology; 2021 Sep; 32(5):654-659. PubMed ID: 34033150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Johns Hopkins Hospital template for urologic cytology samples: parts II and III: improving the predictability of indeterminate results in urinary cytologic samples: an outcomes and cytomorphologic study.
    VandenBussche CJ; Sathiyamoorthy S; Owens CL; Burroughs FH; Rosenthal DL; Guan H
    Cancer Cytopathol; 2013 Jan; 121(1):21-8. PubMed ID: 23192913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of The Paris System to atypical urine cytology samples: correlation with histology and UroVysion
    Miki Y; Neat M; Chandra A
    Cytopathology; 2017 Apr; 28(2):88-95. PubMed ID: 27601215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementing The Paris System for Reporting Urinary Cytology results in a decrease in the rate of the "atypical" category and an increase in its prediction of subsequent high-grade urothelial carcinoma.
    Wang Y; Auger M; Kanber Y; Caglar D; Brimo F
    Cancer Cytopathol; 2018 Mar; 126(3):207-214. PubMed ID: 29278461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytohistological correlation of urine cytology in a tertiary centre with application of the Paris system.
    Rohilla M; Singh P; Rajwanshi A; Gupta N; Srinivasan R; Dey P; Kakkar N
    Cytopathology; 2018 Oct; 29(5):436-443. PubMed ID: 29920811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An institutional experience with The Paris System: A paradigm shift from ambiguous terminology to more objective criteria for reporting urine cytology.
    Roy M; Kaushal S; Jain D; Seth A; Iyer VK; Mathur SR
    Cytopathology; 2017 Dec; 28(6):509-515. PubMed ID: 28833848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Paris System for reporting urinary cytology in daily practice with emphasis on ancillary testing by multiprobe FISH.
    Vlajnic T; Gut A; Savic S; Bubendorf L
    J Clin Pathol; 2020 Feb; 73(2):90-95. PubMed ID: 31467041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should the BK polyomavirus cytopathic effect be best classified as atypical or benign in urine cytology specimens?
    Allison DB; Olson MT; Lilo M; Zhang ML; Rosenthal DL; VandenBussche CJ
    Cancer Cytopathol; 2016 Jun; 124(6):436-42. PubMed ID: 26929126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The usefulness of nuclear area in the diagnosis of high-grade urothelial carcinoma cells in voided urine cytology.
    Sakumo K; Morihashi K; Nakamura A; Nukaya T; Sumitomo M; Nakamura M; Sofue T; Haba R; Itoh T; Kamoshida S; Ohsaki H
    Cytopathology; 2023 Jul; 34(4):295-301. PubMed ID: 36959684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Paris System "atypical urothelial cells" category: can the current criteria be improved?
    Vosoughi A; Ordobazari A; Lora Gonzalez MA; Guido LP; Skiba M; Campuzano-Zuluaga G; Kryvenko ON; Gomez-Fernandez C; Garcia-Buitrago M; Jorda M
    J Am Soc Cytopathol; 2021; 10(1):3-8. PubMed ID: 32732113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytologic evaluation of upper urinary tract specimens: An institutional retrospective study using The Paris System for Reporting Urine Cytology second edition with histopathologic follow-up.
    Khajir G; Sun T; Wang H; Sprenkle PC; Adeniran AJ; Cai G; Levi AW
    Cytopathology; 2024 Mar; 35(2):235-241. PubMed ID: 37916579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Implementing the Paris System for Reporting Urine Cytology in the Performance of Urine Cytology:  A Correlative Study of 124 Cases.
    Hassan M; Solanki S; Kassouf W; Kanber Y; Caglar D; Auger M; Brimo F
    Am J Clin Pathol; 2016 Sep; 146(3):384-90. PubMed ID: 27543983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical follow up and the impact of the Paris system in the assessment of patients with atypical urine cytology.
    Northrup V; Acar BC; Hossain M; Acker MR; Manuel E; Rahmeh T
    Diagn Cytopathol; 2018 Dec; 46(12):1022-1030. PubMed ID: 30375194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyto-histo correlations of plasmacytoid and micropapillary variants of high-grade urothelial carcinoma: do they fit well in The Paris System for reporting urinary cytology?
    Suo L; Vega I; Thrall M
    J Am Soc Cytopathol; 2021; 10(1):20-24. PubMed ID: 32620533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical Category of the Johns Hopkins Template Has Higher Risk of Malignancy than the Paris System but the Paris System Is More Applicable for Suspicious Category.
    Celik B; Kavas G
    Acta Cytol; 2023; 67(4):425-433. PubMed ID: 36731438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.